(Q41763853)

9 October 2017

title

Specific eradication of micrometastases by transfer of tumour-immune T cells from major-histocompatibility-complex congenic mice (English)

1 reference

3 December 2022

main subject

adoptive immunotherapy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826094

3 December 2022

1 reference

3 December 2022

1 reference

3 December 2022

author name string

V. Schirrmacher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826094

3 December 2022

P. von Hoegen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826094

3 December 2022

A. Griesbach

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826094

3 December 2022

H. J. Schild

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826094

3 December 2022

U. Zangemeister-Wittke

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826094

3 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1826094

3 December 2022

publication date

1 January 1991

1 reference

full work available at URL

9 October 2017

http://link.springer.com/content/pdf/10.1007/BF01741332.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF01741332/fulltext.html

3 December 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF01741332

3 December 2022

1 reference

Cancer Immunology, Immunotherapy

3 December 2022

published in

1 reference

9 October 2017

volume

32

1 reference

9 October 2017

issue

6

1 reference

9 October 2017

page(s)

373-381

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01741332

9 October 2017

exact match

0 references

cites work

Modification of tumor cells by a low dose of Newcastle disease virus. II. Augmented tumor-specific T cell response as a result of CD4+ and CD8+ immune T cell cooperation

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01741332

Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfection

21 January 2018

1 reference

12 December 2020

Characterization of effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia

1 reference

12 December 2020

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. III. Postoperative activation of tumor-specific CTLP from mice with metastases requires stimulation with the specific antigen plus additiona

1 reference

12 December 2020

Lymphokine-activated killer cells: a new approach to immunotherapy of cancer

1 reference

12 December 2020

CD4+ helper T cells are required for resistance to a highly metastatic murine tumor.

1 reference

12 December 2020

Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo

1 reference

12 December 2020

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. I. Parameters for optimal therapeutic effects

1 reference

12 December 2020

Recruitment and activation of tumor-specific immune T cells in situ: functional studies using a sponge matrix model

1 reference

12 December 2020

An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts

1 reference

12 December 2020

Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation

1 reference

12 December 2020

In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment

1 reference

12 December 2020

Immunoresistant metastatic tumor variants can re-express their tumor antigen after treatment with DNA methylation-inhibiting agents

1 reference

12 December 2020

Differential expression of H-2 gene products in tumour cells in associated with their metastatogenic properties

1 reference

12 December 2020

Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation

1 reference

12 December 2020

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

12 December 2020

Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells

1 reference

12 December 2020

Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hosts

1 reference

12 December 2020

Cytolytic effector cells against human tumors: distinguishing phenotype and function

1 reference

12 December 2020

T-cell depletion of allogeneic bone marrow prevents acceleration of graft-versus-host disease induced by exogenous interleukin 2

1 reference

12 December 2020

Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti-tumor immunityin vivo and of cytolytic T cellsin vitro

1 reference

12 December 2020

Suggestive evidence that the highly metastatic variant ESb of the T-cell lymphoma Eb is derived from spontaneous fusion with a host macrophage.

1 reference

12 December 2020

Lethal murine graft-versus-host disease in the absence of detectable cytotoxic T lymphocytes

1 reference

12 December 2020

Escape of metastasizing clonal tumor cell variants from tumor-specific cytolytic T lymphocytes

1 reference

12 December 2020

Recruitment and activation of tumor-specific immune T cells in situ. CD8+ cells predominate the secondary response in sponge matrices and exert both delayed-type hypersensitivity-like and cytotoxic T lymphocyte activity

1 reference

12 December 2020

Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. II. Influence of minor histocompatibility antigens on tumor resistance, gamma-interferon induction and cytotoxic response.

1 reference

12 December 2020

Ly-m11: the H-3 region of mouse chromosome 2 controls a new surface alloantigen

1 reference

12 December 2020

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

12 December 2020

Modification of tumor cells by a low dose of Newcastle disease virus. Augmentation of the tumor-specific T cell response in the absence of an anti-viral response

1 reference

12 December 2020

Invasion & Metastasis

11

2

12

N Isakov

1981

1 reference

Journal of the National Cancer Institute

3 December 2022

15

75

595

S Rosenberg

1985

1 reference

3 December 2022

Invasion & Metastasis

20

1

175

V Schirrmacher

1981

1 reference

3 December 2022

Invasion & Metastasis

28

9

117

P Hoegen Von

1989

1 reference

3 December 2022

Identifiers

DOI

10.1007/BF01741332

1 reference

Dimensions Publication ID

9 October 2017

1013986326

0 references

1 reference